
    
      This research plan is implemented in accordance with GCP principles in Sanbo Brain Hospital
      of Capital Medical University.

      Subjects are screened into the group. If the following conditions do not occur (the subject
      withdraws the informed consent, the drug side effects are intolerable, the investigator
      thinks it is not suitable for further testing, etc.), the expected research treatment for
      each subject It will continue until tumor progression or death confirmed by imaging studies,
      but not more than 2 years. Observe the effectiveness index and safety index during the test.
    
  